29.10.2012
- Global drugmakers are paying tens of millions of dollars to settle U.S. allegations that they bribed their way across emerging markets, but harsher penalties may be needed to deter...
09.08.2012
- Denmark's Novo Nordisk hiked its full-year sales and profit targets after rising demand for diabetes drug Victoza and insulins helped the company beat second-quarter expectations...
09.06.2012
- Spain finalised plans to pay off the healthcare debts of its regions on Friday as some pharmacists closed their doors in protest over unpaid bills in the country, where drugmaker...
08.06.2012
- Danish drugmaker Novo Nordisk , the world's biggest insulin maker, said on Friday that U.S. health regulators had extended their review of its new ultra-long-acting insulin Tresiba...
27.04.2012
- Danish drugmaker Novo Nordisk said it expected its U.S. insulin market share to improve and edged up its full-year targets after stiff competition for insulin and disappointing...
20.04.2012
- Watchdog group Public Citizen urged U.S. regulators to withdraw approval of Novo Nordisk's diabetes drug Victoza, saying it increases the risk of serious health problems like...
18.04.2012
- The U.S. Supreme Court ruled on Tuesday in favor of a generic drugmaker in a case over how companies can fight brand-name rivals in an effort to get their cheaper medicines to...
24.01.2012
- European regulators took another step towards opening the market for copies of biotech drugs on by releasing a draft guideline on how companies should test biosimilar medicines...
